| Spherical equivalent | −12.9 (6.0) |
| Age | 48.9 (13.0) |
| Sex (female/male) | 22/14 |
| Choroidal neovascularisation diameter | 1507 (782) |
| Total photodynamic therapy sessions | 3.3 (1.5) |
| ETDRS lines baseline (n = 39) | 9.0 (4.3) |
| ETDRS lines 6 months (n = 38) | 10.2 (3.6) |
| ETDRS lines 12 months (n = 37) | 10.4 (3.6) |
| ETDRS lines 18 months (n = 37) | 10.0 (3.6) |
| ETDRS lines 24 months (n = 34) | 9.7 (3.9) |
| ETDRS lines 30 months (n = 33) | 10.5 (3.6) |
| ETDRS lines 36 months (n = 34) | 9.6 (3.8) |
| ETDRS lines 42 months (n = 33) | 9.7 (3.8) |
| ETDRS lines 48 months (n = 39) | 9.6 (4.2) |
| ETDRS lines gain (baseline-12) | p = 0.006 (Student t test for paired data) |
| ETDRS lines gain (baseline-24) | p = 0.30 (Student t test for paired data) |
| ETDRS lines gain (baseline-36) | p = 0.97 (Student t test for paired data) |
| ETDRS lines gain (baseline-48) | p = 0.38 (Student t test for paired data) |